MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells

Oncotarget

Volumn 6, Issue 32, 2015, Pages 32737-32747

  Wang, Xiaolong ^a   Li, Yaming ^b   Qi, Wenwen ^b   Zhang, Ning ^a   Sun, Mingjuan ^a   Huo, Qiang ^a   Cai, Chang ^a   Lv, Shangge ^b   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Breast cancer; HOXA1; Invasion; MiR 99a; Proliferation

Indexed keywords

MICRORNA; MICRORNA 99A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HOXA1; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; HOMEOBOX A1 PROTEIN; HOMEODOMAIN PROTEIN; MESSENGER RNA; MIRN99 MICRORNA, HUMAN;

ADULT; ARTICLE; BIOINFORMATICS; BREAST CANCER; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; GAIN OF FUNCTION MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; 3' UNTRANSLATED REGION; BINDING SITE; BREAST TUMOR; CELL MOTION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MCF-7 CELL LINE; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; MORTALITY; NUCLEOTIDE SEQUENCE; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TIME FACTOR; TUMOR INVASION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LYMPHATIC METASTASIS; MCF-7 CELLS; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PHENOTYPE; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84946050823     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5355     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians2011; 61:69-90.
2. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell. 2006; 127:679-695.
3. Scully OJ, Bay BH, Yip G, Yu Y. Breast cancer metastasis. Cancer genomics & proteomics. 2012; 9:311-320.
4. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nature medicine. 2006; 12:895-904.
5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001; 294:853-858.
6. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. The New England journal of medicine. 2005; 353:1768-1771.
7. Sreekumar R, Sayan BS, Mirnezami AH, Sayan AE. MicroRNA Control of Invasion and Metastasis Pathways. Frontiers in genetics. 2011; 2:58.
8. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nature medicine. 2008; 14:1271-1277.
9. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer research. 2005; 65: 9628-9632.
10. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. International journal of cancer. 2008; 123:372-379.
11. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello JF. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC medicine. 2008; 6:14.
12. Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, Hu G, Yang Q. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene. 2013.
13. Zhang C, Liu J, Wang X, Wu R, Lin M, Laddha SV, Yang Q, Chan CS, Feng Z. MicroRNA-339-p inhibits colorectal tumorigenesis through regulation of the MDM2/p3 signaling. Oncotarget. 2014; 5:9106.
14. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. Journal of Biological Chemistry. 2008; 283:1026-1033.
15. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell. 2009; 137:1032-1046.
16. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clinical Cancer Research. 2008; 14:1340-1348.
17. Wang X, Zhang N, Huo Q, Sun M, Lv S, Yang Q. Huaier aqueous extract suppresses human breast cancer cell proliferation through inhibition of estrogen receptor a signaling. International journal of oncology. 2013; 43:321-328.
18. Wang X, Zhang N, Huo Q, Yang Q. Anti-angiogenic and antitumor activities of Huaier aqueous extract. Oncology reports. 2012; 28:1167-1175.
19. Heckman KL, Pease LR. Gene splicing and mutagenesis by PCR-driven overlap extension. Nature protocols. 2007; 2:924-932.
20. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research. (Database issue). 2011; 39:D202-209.
21. Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIPSeq data. Nucleic acids research. 2014; 42:D92-97.
22. Wardwell-Ozgo J, Dogruluk T, Gifford A, Zhang Y, Heffernan T, Van Doorn R, Creighton C, Chin L, Scott K. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene. 2013; 33:1017-1026.
23. Zhan M, Qu Q, Wang G, Liu Y-Z Tan S-L, Lou X-Y Yu, J Zhou H-H. Let-7c Inhibits NSCLC Cell Proliferation by Targeting HOXA1. Asian Pacific Journal of Cancer Prevention. 2013; 14:387-392.
24. Wu Q, Yang Z, An Y, Hu H, Yin J, Zhang P, Nie Y, Wu K, Shi Y, Fan D. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1. Cell death & disease. 2014; 5:e1144.
25. Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. 2014; 33:1181-1189.
26. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor STF, Chin AR. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer cell. 2014; 25:501-515.
27. Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, Rappsilber J, Mann M, Dreyfuss G. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes & development. 2002; 16:720-728.
28. Kuo YZ, Tai YH, Lo HI, Chen YL, Cheng HC, Fang WY, Lin SH, Yang CL, Tsai ST, Wu LW. MiR-99a exerts antimetastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral diseases. 2014; 20:e65-75.
29. Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. Journal of Biological Chemistry. 2011; 286:36677-36685.
30. Kuo YZ, Tai YH, Lo HI, Chen YL, Cheng HC, Fang WY, Lin SH, Yang CL, Tsai ST, Wu LW. MiR-99a exerts antimetastasis through inhibiting myotubularin-related protein 3 expression in oral cancer. Oral diseases. 2014; 20:e65-e75.
31. Cui L, Zhou H, Zhao H, Zhou Y, Xu R, Xu X, Zheng L, Xue Z, Xia W, Zhang B. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC cancer. 2012; 12:546.
32. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C, Jensen RV, Moskaluk CA, Dutta A. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer research. 2011; 71:1313-1324.
33. Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao Y, Sun N, Xu X, Shao K, He J. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Medical Oncology. 2013; 30:1-9.
34. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nature Reviews Cancer. 2010; 10:361-371.
35. Cillo C, Cantile M, Faiella A, Boncinelli E. Homeobox genes in normal and malignant cells. Journal of cellular physiology. 2001; 188:161-169.
36. Grier D, Thompson A, Kwasniewska A, McGonigle G, Halliday H, Lappin T. The pathophysiology of HOX genes and their role in cancer. The Journal of pathology. 2005; 205:154-171.
37. Abe M, Hamada J-I, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T. Disordered expression of HOX genes in human non-small cell lung cancer. Oncology reports. 2006; 15:797-802.
38. Brock A, Krause S, Li H, Kowalski M, Goldberg MS, Collins JJ, Ingber DE. Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Science translational medicine. 2014; 6:217ra212-217ra212.
39. Rice KL, Licht JD. HOX deregulation in acute myeloid leukemia. Journal of Clinical Investigation. 2007; 117:865-868.
40. Friedmann Y, Daniel CA, Strickland P, Daniel CW. Hox genes in normal and neoplastic mouse mammary gland. Cancer research. 1994; 54:5981-5985.
41. Cantile M, Pettinato G, Procino A, Feliciello I, Cindolo L, Cillo C. In vivo expression of the whole HOX gene network in human breast cancer. European Journal of Cancer. 2003; 39:257-264.
42. Zhang X, Zhu T, Chen Y, Mertani HC, Lee K-O, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. Journal of Biological Chemistry. 2003; 278:7580-7590.